UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2017$397,465,000
-32.6%
66,134
-37.8%
0.00%
-100.0%
Q3 2017$590,032,000
+19.6%
106,3120.0%0.00%
Q2 2017$493,288,000
-4.8%
106,312
+1.6%
0.00%
-100.0%
Q1 2017$518,161,000
+37777.3%
104,679
-15.1%
0.00%
-50.0%
Q4 2016$1,368,000
+20.8%
123,235
+0.9%
0.00%
+100.0%
Q3 2016$1,132,000
+20.2%
122,176
-17.7%
0.00%0.0%
Q2 2016$942,000
-3.0%
148,377
-0.3%
0.00%0.0%
Q1 2016$971,000
+21.5%
148,891
+51.1%
0.00%0.0%
Q4 2015$799,000
-68.2%
98,558
-71.3%
0.00%
-66.7%
Q3 2015$2,513,000
-14.3%
342,857
+19.8%
0.00%0.0%
Q2 2015$2,934,000286,2990.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q1 2018
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 20,150$00.00%
Advisory Services Network, LLC 2,233$00.00%
Fernwood Investment Management, LLC 34,000$00.00%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders